Cystogenesis -
-30% ar kodu BOOKS
Piegāde 15-21 darba dienu laikā
30 dienu atgriešanas politika
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a highly prevalent hereditary renal disorder in which fluid-filled cysts are appeared in both kidneys. Main causative genes of ADPKD are PKD1 and PKD2, encoding for polycystin-1 (PC1) and polycystin-2 (PC2) respectively. Those proteins are localized on primary cilia and function as mechanosensor in response to the fluid flow, translating mechanistic st ... Pilns apraksts
Jums varētu patikt arī
TOP
The Myth of Normal: Trauma, Illness, and Healing in a Toxic Culture
-30% ar kodu BOOKS
Piegādātāja noliktavā
TOP
The Body Keeps the Score: Brain, Mind, and Body in the Healing of Trauma
-30% ar kodu BOOKS
Piegādātāja noliktavā
TOP
No Bad Parts: Healing Trauma and Restoring Wholeness with the Internal Family Systems Model
-30% ar kodu BOOKS
Piegādātāja noliktavā
TOP
On Connection: 'Powerful' MATT HAIG
-30% ar kodu BOOKS
Piegādātāja noliktavā
TOP
Oxford Handbook of Clinical Medicine
Peter Hateley, Iain McGurgan, Ian B. Wilkinson, Tim Raine, Dearbhla Kelly, Kate Wiles
-30% ar kodu BOOKS
Piegādātāja noliktavā
TOP
Harrison's Principles of Internal Medicine (Vol.1 & Vol.2)
Stephen Hauser, Joseph Loscalzo, Steven Holland, Dan Longo, J. Larry Jameson, Dennis Kasper, Carol Langford, Anthony Fauci
-30% ar kodu BOOKS
Piegādātāja noliktavā
TOP
The Checklist Manifesto: How to Get Things Right
-30% ar kodu BOOKS
Piegādātāja noliktavā
TOP
Maybe You Should Talk to Someone: a therapist, her thearapist, and our lives revealed
-30% ar kodu BOOKS
Piegādātāja noliktavā
TOP
How Not To Die: Discover the foods scientifically proven to prevent and reverse disease
-30% ar kodu BOOKS
Piegādātāja noliktavā
TOP
Lifespan: Why We Age - and Why We Don't Have To
-30% ar kodu BOOKS
Piegādātāja noliktavā
TOP
Vademecum Metabolicum: Diagnosis and Treatment of Inborn Errors of Metabolism Forword by William L. Nyhan, San Diego, USA
Johannes Zschocke, Georg F. Hoffmann
-30% ar kodu BOOKS
Piegādātāja noliktavā
TOP
Cellular and Molecular Immunology
Sarah Henrickson, Abul K. Abbas, Andrew H. Lichtman, Shiv Pillai
-30% ar kodu BOOKS
Piegādātāja noliktavā
TOP
Physics, Pharmacology and Physiology for Anaesthetists: Key Concepts for the FRCA
Matthew E. Cross, Emma V. E. Plunkett
-30% ar kodu BOOKS
Piegādātāja noliktavā
TOP
Being Mortal: Medicine and What Matters in the End
-30% ar kodu BOOKS
Piegādātāja noliktavā
TOP
Pocket Guide to Teaching for Clinical Instructors
-30% ar kodu BOOKS
Piegādātāja noliktavā
TOP
Oxford Handbook of Critical Care
Andrew Webb, Mervyn Singer, Alice Carter
-30% ar kodu BOOKS
Piegādātāja noliktavā
TOP
Who Deserves Your Love: How to Create Boundaries to Start, Strengthen or End Any Relationship
-30% ar kodu BOOKS
Piegādātāja noliktavā
TOP
Vaccinated - dead: Histopathological findings following COVID-19 vaccination
-30% ar kodu BOOKS
Piegādātāja noliktavā
Aprašymas
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a highly prevalent hereditary renal disorder in which fluid-filled cysts are appeared in both kidneys. Main causative genes of ADPKD are PKD1 and PKD2, encoding for polycystin-1 (PC1) and polycystin-2 (PC2) respectively. Those proteins are localized on primary cilia and function as mechanosensor in response to the fluid flow, translating mechanistic stimuli into calcium signaling. With mutations either of PKD1 or PKD2, hyper-activated renal tubular epithelial cell proliferation is observed, followed by disrupted calcium homeostasis and aberrant intracellular cyclic AMP (cAMP) accumulation. Increased cell proliferation with fluid secretion leads to the development of thousands of epithelial-lined, fluid-filled cysts in kidneys. It is also accompanied by interstitial inflammation, fibrosis, and finally reaching end-stage renal disease (ESRD). In human ADPKD, the age at which renal failure typically occurs is later in life, however no specific targeted medications are available to cure ADPKD. Recently, potential therapeutic targets or surrogate diagnostic biomarkers for ADPKD are proposed with the advances in the understanding of ADPKD pathogenesis, and some of them were attempted for clinical trials. Herein, we will summarize genetic and epi-genetic molecular mechanisms in ADPKD progression, and overview the currently available biomarkers or potential therapeutic reagents suggested.
Vairāk informācijas
| Izdevējs | Springer Nature Singapore |
|---|---|
| Izlaides gads | 2018 |
| Vāka tips | Mīkstais vāks |
| EAN | 9789811095115 |